Philipps-Universitaet Marburg — Marburg, Hesse

Public research footprint of Philipps-Universitaet Marburg, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Aggressive Diffuse Large B-cell Lymphoma · Parkinson's Disease (PD) · Leukemia, Myeloid, Acute · Refractory Cancer

Recently updated registry entries

NCT07197307 — Combining Loncastuximab Tesirine and Epcoritamab in Relapsed/Refractory Diffuse Large… (Recruiting)
NCT06585774 — A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic… (Recruiting)
NCT05258071 — A Clinical Study Evaluating Efficacy of Pirepemat on Falls Frequency in Patients With… (Completed)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Philipps-Universitaet Marburg?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.